Cardlytics Q2 net loss narrows to $23.5M; revenue up 2% YoY to $76.7M

Cardlytics, Inc.

2024-Q2 EPS reported -$0.29 revenue$141,032,000

Revenue $76.7M (+2% YoY); gross profit $30.5M (+13% YoY).
Net loss attributable to common stockholders $23.5M ($0.67/share) vs $126.3M ($3.75/share) YoY.
Adjusted EBITDA loss improved to $4.1M from $15.8M loss in Q2 2022.
MAUs grew 5% to 188.1M; ARPU flat at $0.38.
Q3 2023 guidance: revenue $75-84M, adjusted EBITDA $(2M) to $2M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cardlytics, Inc. reported second quarter ended June 30, 2023 results: revenue $76.7 million, net income $(23.5) million, EPS $(0.67) per diluted share.

Period: second quarter ended June 30, 2023
Revenue: $76.7 million
Net income: $(23.5) million
EPS: $(0.67) per diluted share
Result: reported results

Exact text from the filing

and the organizational changes we are making continue to give our teams room to operate with speed and a clear focus." Second Quarter 2023 Financial Results • Revenue was $76.7 million, an increase of 2% year-over-year, compared to $75.4 million in the second quarter of 2022. • Billings, a non-GAAP metric, was $109.4 million, an increase of 2% year-over-year,

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001666071-23-000103

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.